Cargando…

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology

Detalles Bibliográficos
Autores principales:	Battistelli, Cecilia, Cordani, Marco, Diederich, Marc, Somoza, Álvaro, Valente, Sergio, Strippoli, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378211/ https://www.ncbi.nlm.nih.gov/pubmed/34421627 http://dx.doi.org/10.3389/fphar.2021.742777

Ejemplares similares

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Editorial: Natural Product Epigenetic Modulators and Inhibitors
por: Ntie-Kang, Fidele, et al.
Publicado: (2021)

Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment
por: Sharma, Priyanka, et al.
Publicado: (2020)

Editorial: Novel Cancer Treatments Based on Autophagy Modulation
por: Cordani, Marco, et al.
Publicado: (2021)

Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment
por: Cordani, Marco, et al.
Publicado: (2019)

Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
por: Strippoli, Raffaele, et al.
Publicado: (2016)

TGFβ Impairs HNF1α Functional Activity in Epithelial-to-Mesenchymal Transition Interfering With the Recruitment of CBP/p300 Acetyltransferases
por: Bisceglia, Francesca, et al.
Publicado: (2019)

Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers
por: Cordani, Marco, et al.
Publicado: (2023)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
por: Dong, Bo, et al.
Publicado: (2020)

Editorial: Emerging Micro- and Nanotechnologies for Medical and Pharmacological Applications
por: Xiao, Yufen, et al.
Publicado: (2021)

Editorial: Advanced nanotechnological detection and drug delivery configurations
por: Hashemi, Seyyed Alireza, et al.
Publicado: (2023)

Editorial: Phytochemical-based nanoformulations to tackle drug resistance in cancer
por: Tuli, Hardeep Singh, et al.
Publicado: (2023)

Targeting of polycombs to DNA in EMT
por: Battistelli, Cecilia, et al.
Publicado: (2017)

SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
por: Magistri, Paolo, et al.
Publicado: (2018)

Editorial: Targeting tumor EMT-related signaling by natural products
por: Anwar, Sirajudheen, et al.
Publicado: (2023)

Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis
por: Schnekenburger, Michael, et al.
Publicado: (2014)

Nanotechnology Approaches in Tackling Cardiovascular Diseases
por: Prajnamitra, Ray Putra, et al.
Publicado: (2019)

Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment
por: Cordani, Marco, et al.
Publicado: (2018)

Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
por: Terri, Michela, et al.
Publicado: (2021)

A novel RNA-based approach to counteract EMT
por: Garbo, Sabrina, et al.
Publicado: (2021)

Editorial: Next-Generation Cancer Therapies Based on a (R)evolution of the Biomarker Landscape
por: Cerella, Claudia, et al.
Publicado: (2022)

Editorial: Natural products as potential therapeutics to tackle life-threatening infections: From field to market
por: Rahman, M. Mukhlesur
Publicado: (2022)

Ketamine Induced Bladder Fibrosis Through MTDH/P38 MAPK/EMT Pathway
por: Zhu, Quan, et al.
Publicado: (2022)

Editorial: Pulmonary fibrosis: One manifestation, various diseases
por: Ruaro, Barbara, et al.
Publicado: (2022)

Editorial: The Cell Types of Fibrosis
por: Murray, Lynne A.
Publicado: (2016)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Nanotechnology for Targeted Therapy of Atherosclerosis
por: Hossaini Nasr, Seyedmehdi, et al.
Publicado: (2021)

Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective
por: Trandafir, Laura M., et al.
Publicado: (2022)

Editorial: Epigenetic regulation and therapy resistance in cancer
por: Zhu, Yongxia, et al.
Publicado: (2023)

Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity
por: Re, Francesca, et al.
Publicado: (2023)

Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling
por: Hu, Lichao, et al.
Publicado: (2022)

Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells
por: García-Garrido, Eduardo, et al.
Publicado: (2021)

The Potential of Nanotechnology in Medically Assisted Reproduction
por: Remião, Mariana H., et al.
Publicado: (2018)

Potential Applications of Nanotechnology in Urological Cancer
por: He, Ming-Hui, et al.
Publicado: (2018)

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023)

Sirtuins and Hypoxia in EMT Control
por: Aventaggiato, Michele, et al.
Publicado: (2022)

Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia
por: Yao, Yufeng, et al.
Publicado: (2018)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Editorial: Premature Aging and Senescence in Renal Fibrosis
por: Samarakoon, Rohan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kallsvkhu6lkp69gqf1k6dd9g5